Please login to the form below
accessibility
This page shows the latest accessibility news and features for those working in and with pharma, biotech and healthcare.
FDA issues new draft guidance on decentralised clinical trials
needs’. 'By reducing barriers to participation, we expect that DCTs will increase the breadth and diversity of participants in clinical trials and improve accessibility for those with rare diseases or mobility
Latest news
-
US government announces first set of drugs subject to Medicare inflation rebates
Last month, the US health department proposed three new models to help promote accessibility and improve quality of care for those enrolled in voluntary government health insurance plans.
-
US health department proposes three new models to help lower cost of drugs
The US health department has proposed three new models to help lower the cost of drugs, promote accessibility and improve quality of care for those enrolled in voluntary government health insurance
-
Neurodiversity and healthcare communications – do we know enough and do we do enough?
Surprisingly though, when comparing the number of articles on PubMed on the accessibility of health information for the neurodiverse community (n=110) versus the accessibility of health information for the general ... Advisory board meetings, steering
-
Seeing AI app launched by Haleon and Microsoft to enhance sight accessibility
Haleon and Microsoft Corporation (Microsoft) announced a new collaboration on World Sight Day 2022 to enhance the accessibility of product labels for those who are blind, partially sighted or have difficulty
-
Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
While congress works toward additional COVID-19 funding, Lilly and the US government will continue to work together to support the availability of bebtelovimab to maximise equity and accessibility in the
More from news
Approximately 1 fully matching, plus 72 partially matching documents found.
Latest Intelligence
-
Next congress, please: making the most of virtual pharmaceutical congresses
Healthcare, especially, rapidly changed its accessibility and delivery, swapping freedoms with limitations and final farewells with FaceTime calls. ... Flexibility: on-demand access to content allows learning anywhere, anytime. Accessibility: virtual
-
Meeting healthcare’s rising challenges
Digital tools are also exerting an increasing influence on drug development, clinical trials, accessibility and adherence, while industry and patient groups are forging stronger connections – and understanding – through apps and AI.
-
Patient support programmes: providing meaningful care when you dare to treat rare
Accessibility. While accessibility is relevant for all PSPs, it’s vital to consider the demographic of patients likely to be using it, their comprehension and ways in which they will be ... Examples of accessibility that can have a huge positive impact
-
Collaboration over complacency in reshaping the future of cardiovascular care
As an industry, our role is to be a steadfast partner to help contribute to the accessibility of medicines and advancement of approaches to care; however, I believe this can only
-
Delivering content to fuel omnichannel engagement
This enhances audience engagement and improves the impact of medical education through accessibility, convenience and relevance.
More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.
Latest appointments
-
Changes at Oxford PharmaGenesis, Synergy Vision and akt health communications
underpinned by relevant local knowledge and accessibility for clients around the world.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Article: Could combating stigma increase the uptake of PrEP and finally end the HIV epidemic?
The prevalence of stigma and accessibility issues are key barriers to the prevention of reducing HIV infection further by limiting the uptake of treatment amongst some high-risk target groups.
-
Thinking creatively about patient involvement in publications
Patient involvement in end-to-end publication planning and development has the potential to add huge value through improving accessibility of clinical trial data to non-specialist audiences.
-
Cuttsy+Cuttsy campaign takes health literacy to the North Pole
health literacy and accessibility take centre stage in our festive campaign.
-
Precision versus personalised medicine
Whilst whole-genome sequencing offers considerable diagnostic benefits for patients, there remain considerable barriers to its widespread implementation in clinical practice, including lack of reimbursement, limited accessibility, and inadequate
-
The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia
And while regenerative and curative therapies are often greatly lauded, there are also challenges in treating affected patient populations, including cost, accessibility, side effects, and other associated risks.
More from PMHub
Approximately 1 fully matching, plus 32 partially matching documents found.
Subscribe to our email news alerts
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Pfizer reports positive results for elranatamab in multiple myeloma
- BMS presents positive four-year results for Opdivo combination in lung cancer
- AstraZeneca to stop post-marketing study of Andexxa following early success
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- European Commission grants two new marketing authorisations for UCB's Bimzelx
- AstraZeneca/Sanofi’s RSV antibody backed by FDA advisory committee for infants
- Janssen shares positive phase 3 results for cilta-cel in multiple myeloma
- Parkinson’s disease: past, present and future
- How to Increase Engagement During Virtual Events
- AstraZeneca to stop post-marketing study of Andexxa following early success
No results were found
PMHub
Evoke Kyne
Evoke Kyne is an award-winning communications agency that harnesses insight, experience and creativity to advance health and wellbeing around the world. We were founded on the belief that...
Latest intelligence
- Parkinson’s disease: past, present and future
- Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
